Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
APPLICATION OF VIPER VENOM HEMOCOAGULASE IN PREPARATION OF DRUG FOR REVERSING ANTICOAGULATION EFFECT OF BLOOD COAGULATION FACTOR XA INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2023/168743
Kind Code:
A1
Abstract:
Disclosed is an application of viper venom hemocoagulase in the preparation of a drug for reversing the anticoagulation effect of a blood coagulation factor Xa inhibitor. By means of research on the ability of Slounase, which is a viper venom hemocoagulase, serving as a hemostatic bypass agent to reverse the anticoagulation effect of the blood coagulation factor Xa inhibitor, it is found that Slounase can reverse the anticoagulation effect of the blood coagulation factor Xa inhibitor in a dose-dependent manner, and thrombus formation in human blood can be completely recovered. The treatment potential of Slounase in reversing the anticoagulation effect of the blood coagulation factor Xa inhibitor clinically used at present is confirmed, and a new rescue treatment means is provided for bleeding caused by the blood coagulation factor Xa inhibitor.

Inventors:
ADILI REHEMAN (CN)
DAI XIANGRONG (CN)
CHEN CHENG (CN)
LI XIAOYI (CN)
Application Number:
PCT/CN2022/081569
Publication Date:
September 14, 2023
Filing Date:
March 18, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ZHAOKE PHARMACEUTICAL HEFEI CO LTD (CN)
International Classes:
A61P7/02; A61K38/48
Domestic Patent References:
WO2014118677A12014-08-07
Foreign References:
CN104755492A2015-07-01
CN101802188A2010-08-11
CN108785665A2018-11-13
CN101214374A2008-07-09
Other References:
"Obstetrics and Gynecology Drug Quick Reference Manual", 31 August 2009, PEOPLE'S MILITARY MEDICAL PUBLISHING HOUSE, CN, ISBN: 978-7-5091-2894-7, article LE, JIE: "IX. Hemocoagulase Injection", pages: 146, XP009549446
Attorney, Agent or Firm:
BEIJING EASTKING PATENT AGENT FIRM (CN)
Download PDF: